Melinta Therapeutics Inc (MLNTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -85,212 | -29,432 | -58,916 | -40,136 | -20,499 |
| Depreciation Amortization | 8,494 | 4,805 | 451 | 368 | 221 |
| Accounts receivable | -3,169 | -5,868 | -3,140 | -7,071 | -3,825 |
| Accounts payable and accrued liabilities | 4,632 | 3,983 | -1,269 | 7,303 | 3,435 |
| Other Working Capital | -22,282 | -12,211 | -1,353 | 77 | 1,250 |
| Other Operating Activity | -8,212 | -12,696 | -11,371 | 5,856 | 4,983 |
| Operating Cash Flow | $-105,749 | $-51,419 | $-75,598 | $-33,603 | $-14,435 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -927 | -504 | -849 | -791 | -593 |
| Net Acquisitions | -166,383 | -166,383 | 161,410 | N/A | N/A |
| Purchase Sale Intangibles | -2,000 | N/A | -5,500 | -3,500 | -2,000 |
| Other Investing Activity | -2,000 | 0 | -5,500 | -3,500 | -2,000 |
| Investing Cash Flow | $-169,310 | $-166,887 | $155,061 | $-4,291 | $-2,593 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 112,893 | 112,893 | 63,370 | 64,526 | 54,526 |
| Debt Repayment | -47,609 | -47,609 | -24,503 | -24,503 | -24,503 |
| Common Stock Issued | 240,478 | 124,719 | 88 | 95 | 95 |
| Other Financing Activity | -9,003 | -8,605 | -1,240 | -1,240 | -1,240 |
| Financing Cash Flow | $296,759 | $181,398 | $37,715 | $38,878 | $28,878 |
| Beginning Cash Position | 128,587 | 128,587 | 11,409 | 11,409 | 11,409 |
| End Cash Position | 150,287 | 91,679 | 128,587 | 12,393 | 23,259 |
| Net Cash Flow | $21,700 | $-36,908 | $117,178 | $984 | $11,850 |
| Free Cash Flow | |||||
| Operating Cash Flow | -105,749 | -51,419 | -75,598 | -33,603 | -14,435 |
| Capital Expenditure | -927 | -504 | -849 | -791 | -593 |
| Free Cash Flow | -106,676 | -51,923 | -76,447 | -34,394 | -15,028 |